Australian comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein (Eloctate®)

Haemophilia. 2020 Sep;26(5):e226-e229. doi: 10.1111/hae.14038. Epub 2020 Jun 12.

Authors

Geoffrey Kershaw^{1

2}, Vivien M Chen^{2

3}, Nancy Cai¹, Teh-Liane Khoo¹

Affiliations

¹ Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
² Anzac Research Institute, University of Sydney, Sydney, NSW, Australia.
³ Haematology Department, Concord Repatriation General Hospital, Concord, NSW, Australia.

PMID: 32530128
DOI: 10.1111/hae.14038

No abstract available

Publication types

Letter

MeSH terms

Australia
Factor VIII / metabolism*
Humans
Immunoglobulin Fc Fragments
Recombinant Fusion Proteins

Substances

Immunoglobulin Fc Fragments
Recombinant Fusion Proteins
factor VIII-Fc fusion protein
Factor VIII

Grants and funding

Biogen Idec